Kodama Kota

Affiliation and department：
Job title： Professor
Other affiliations (2)：

Research field (4)： Pharmaceuticals - chemistry and drug development , Systems genomics , Genomics , Business administration

Research theme for competitive and other funds (10)：

2024 - 2025 Co-operation between institutions/regulations and innovation, and corporate behaviour
2021 - 2025 Co-operation between institutions/regulations and innovation, and corporate behaviour
2020 - 2024 A Study on Local Initiatives in University Ventures
2020 - 2022 Empirical study on Pareto efficiency related to industry, medical care and insurance in anti-cancer drug treatment
2018 - 2021 Inhibitor development of Pseudomonas aeruginosa MurD using a novel molecular design method targeting the conformation changing process.

Show all

Papers (65)：

Jiei Sasaki, Akihiko Sato, Michihito Sasaki, Iori Okabe, Kota Kodama, Satoko Otsuguro, Kosuke Yasuda, Hirotatsu Kojima, Yasuko Orba, Hirofumi Sawa, et al. X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates. Antiviral Research. 2024
Hanlin Feng, Makoto Niwa, Jianfei Cao, Karin Kurata, Shuo Zhang, Yenogjoo Lim, Tack Joong Kim, Xitong Guo, Itsuki Kageyama, Kota Kodama. Promoting the social implementation of digital and mobile health: effects of regulation on user and non-user behavior in East Asia. Drug Discovery Today. 2024. 29. 10. 104136-104136
Hanlin Feng, Karin Kurata, Jianfei Cao, Kageyama Itsuki, Makoto Niwa, Atsushi Aoyama, Kota Kodama. Telemedicine Research Trends in 2001-2022 and Research Cooperation Between China and Other Countries Before and After the COVID-19 Pandemic: Bibliometric Analysis. Interactive Journal of Medical Research. 2024. 13. e40801-e40801
Jianfei Cao, Hanlin Feng, Yeongjoo Lim, Kota Kodama, Shuo Zhang. How Social Influence Promotes the Adoption of Mobile Health among Young Adults in China: A Systematic Analysis of Trust, Health Consciousness, and User Experience. Behavioral sciences (Basel, Switzerland). 2024. 14. 6
Kentaro Yashiro, Yeongjoo Lim, Shintaro Sengoku, Atsushi Aoyama, Kota Kodama. The rise of spin-offs: Fueling pharmaceutical innovation through collaboration. Journal of Open Innovation: Technology, Market, and Complexity. 2024. 10. 1

ｍore...

MISC (57)：

塩谷和昭, 児玉耕太. 希少疾患に対する研究開発環境の変化とドラッグロス. バイオサイエンスとインダストリー / バイオサイエンスとインダストリー編集委員会編. 2024. 82. 2. 206-209
Kazuaki Enya, Yeongjoo Lim, Shintaro Sengoku, Kota Kodama. Increasing orphan drug loss in Japan: Trends and R&D strategy for rare diseases. Drug Discovery Today. 2023. 28. 10. 103755-103755
児玉耕太. Effect of external innovation for advanced pharmaceutical R&D: a case of monoclonal antibody. Proceeding of PICMET. 2022. in press
松永, 淳, 仙石, 慎太郎, 児玉, 耕太. スタートアップのExitに影響する要因の階層分離 : 先行研究レビューに基づく試み. 年次学術大会講演要旨集. 2020. 35. 749-752
児玉耕太. Trends of high throughput methods from literature survey ? innovation dynamics and globalization. Bioanalysis. 2020. in press

ｍore...

Patents (9)：

ｍore...

Professional career (1)：

Awards (3)：

2023/10 - ITヘルスケア学会研究奨励賞
2019/08 - EHESS Fondation France-Japon de l'EHESS fellow
2005/07 - Controlled Release Society Innovative Aspects of Oral Drug Delivery and Absorption Graduate/ Postdoc Award

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page